Circuits regulating pleasure and happiness - focus on potential biomarkers for circuitry including the habenuloid complex; Acta Neuropsychiatrica; Vol. 34, iss. 5
| Parent link: | Acta Neuropsychiatrica Vol. 34, iss. 5.— 2022.— [P. 229-239] |
|---|---|
| Autor principal: | |
| Autor corporatiu: | |
| Altres autors: | |
| Sumari: | Title screen Introduction: The multiplicity and complexity of the neuronal connections in the central nervous system make it difficult to disentangle circuits that play an essential role in the development or treatment of (neuro)psychiatric disorders. By choosing the evolutionary development of the forebrain as a starting point, a certain order in the connections can be created. The dorsal diencephalic connection (DDC) system can be applied for the development of biomarkers that can predict treatment response. Materials and methods: After providing a brief introduction to the theory, we examined neuroanatomical publications on the connectivity of the DDC system. We then searched for neurochemical components that are specific for the habenula. Results and discussion: The best strategy to find biomarkers that reflect the function of the habenular connection is to use genetic variants of receptors, transporters or enzymes specific to this complex. By activating these with probes and measuring the response in people with different functional genotypes, the usefulness of biomarkers can be assessed. Conclusions: The most promising biomarkers in this respect are those linked to activation or inhibition of the nicotine receptor, dopamine D4 receptor, μ-opioid receptor and also those of the functioning of habenular glia cells (astrocytes and microglia). |
| Idioma: | anglès |
| Publicat: |
2022
|
| Matèries: | |
| Accés en línia: | https://doi.org/10.1017/neu.2022.15 |
| Format: | Electrònic Capítol de llibre |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=668305 |
MARC
| LEADER | 00000naa0a2200000 4500 | ||
|---|---|---|---|
| 001 | 668305 | ||
| 005 | 20250313162115.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\39530 | ||
| 035 | |a RU\TPU\network\38126 | ||
| 090 | |a 668305 | ||
| 100 | |a 20220927d2022 k||y0rusy50 ba | ||
| 101 | 0 | |a eng | |
| 102 | |a GB | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Circuits regulating pleasure and happiness - focus on potential biomarkers for circuitry including the habenuloid complex |f A. J. M. Loonen, S. A. Ivanova | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 330 | |a Introduction: The multiplicity and complexity of the neuronal connections in the central nervous system make it difficult to disentangle circuits that play an essential role in the development or treatment of (neuro)psychiatric disorders. By choosing the evolutionary development of the forebrain as a starting point, a certain order in the connections can be created. The dorsal diencephalic connection (DDC) system can be applied for the development of biomarkers that can predict treatment response. Materials and methods: After providing a brief introduction to the theory, we examined neuroanatomical publications on the connectivity of the DDC system. We then searched for neurochemical components that are specific for the habenula. Results and discussion: The best strategy to find biomarkers that reflect the function of the habenular connection is to use genetic variants of receptors, transporters or enzymes specific to this complex. By activating these with probes and measuring the response in people with different functional genotypes, the usefulness of biomarkers can be assessed. Conclusions: The most promising biomarkers in this respect are those linked to activation or inhibition of the nicotine receptor, dopamine D4 receptor, μ-opioid receptor and also those of the functioning of habenular glia cells (astrocytes and microglia). | ||
| 461 | |t Acta Neuropsychiatrica | ||
| 463 | |t Vol. 34, iss. 5 |v [P. 229-239] |d 2022 | ||
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a (neuro)psychiatry | |
| 610 | 1 | |a mental disorders | |
| 610 | 1 | |a evolutionbased theory | |
| 610 | 1 | |a habenula | |
| 610 | 1 | |a forebrain circuitry | |
| 610 | 1 | |a biomarkers | |
| 610 | 1 | |a нейропсихиатрия | |
| 610 | 1 | |a психические расстройства | |
| 610 | 1 | |a эволюционная теория | |
| 610 | 1 | |a биомаркеры | |
| 700 | 1 | |a Loonen |b A. J. M. |g Anton | |
| 701 | 1 | |a Ivanova |b S. A. |c specialist in the field of ecology and life safety |c Professor of Tomsk Polytechnic University, doctor of medical sciences |f 1964- |g Svetlana Aleksandrovna |3 (RuTPU)RU\TPU\pers\33859 | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет |b Инженерная школа неразрушающего контроля и безопасности |b Отделение контроля и диагностики |3 (RuTPU)RU\TPU\col\23584 |
| 801 | 0 | |a RU |b 63413507 |c 20230329 |g RCR | |
| 856 | 4 | |u https://doi.org/10.1017/neu.2022.15 | |
| 942 | |c CF | ||